Delcath Systems Inc. (NASDAQ:DCTH) shares shot up 47.6% on Thursday . The stock traded as high as $5.83 and last traded at $5.83, with a volume of 154,265 shares. The stock had previously closed at $3.95.

The stock’s 50 day moving average is $4.00 and its 200 day moving average is $4.63. The company’s market capitalization is $6.40 million.

Delcath Systems (NASDAQ:DCTH) last posted its quarterly earnings data on Wednesday, May 4th. The medical device company reported ($0.08) earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.11. Analysts anticipate that Delcath Systems Inc. will post ($7.84) earnings per share for the current year.

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.